Oxford Asset Management’s Ardent Health ARDT Stock Holding History

Oxford Asset Management’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,390	Closed	-$280K	–	802
2025 Q1	$280K	Buy	+20,390	New	+$298K	0.13%	268

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Oxford Asset Management's ARDT Position: Q2 2025 in Review

Oxford Asset Management sold out of Ardent Health (ARDT) in Q2 2025, closing a stake of 20,390 shares — an estimated $280K sold.

Oxford Asset Management first reported a position in ARDT in Q1 2025 and held it in 1 quarter. The position peaked at $280K in Q1 2025. 110 funds tracked by Wall St. Rank hold ARDT as of Q2 2025.

Oxford Asset Management reported no remaining Ardent Health position as of Q2 2025 after selling out during the quarter.
Oxford Asset Management sold 20,390 Ardent Health shares in Q2 2025, an estimated $280K.
Oxford Asset Management first reported a position in Ardent Health in Q1 2025 and held it in 1 quarter.
Oxford Asset Management's Ardent Health position peaked at $280K in Q1 2025.
110 funds tracked by Wall St. Rank held Ardent Health as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.